A systematic dilution study of self-microemulsifying drug delivery systems in artificial intestinal fluid using dynamic laser light backscattering

Drug Development and Industrial Pharmacy

Volumn 35, Issue 2, 2009, Pages 199-208

  Ditner, Céline ^a   Bravo, Roberto ^b   Imanidis, Georgios ^c   Kuentz, Martin ^c  

^a UNIVERSITY OF BASEL   (Switzerland)

^b ACTELION PHARMACEUTICALS LTD   (Switzerland)

^c UNIVERSITY OF APPLIED SCIENCES AND ARTS NORTHWESTERN SWITZERLAND   (Switzerland)

Author keywords

Artificial intestinal fluid; Dilution test; Oral drug absorption; Self microemulsifying drug delivery systems; Statistical design

Indexed keywords

ARTICLE; DILUTION; DRUG DELIVERY SYSTEM; DRUG SCREENING; EXPERIMENTATION; IN VITRO STUDY; INTESTINE FLUID; LIGHT SCATTERING; MICELLE; PARAMETER; PARTICLE SIZE; ROOM TEMPERATURE; SELF CONCEPT; STATISTICAL SIGNIFICANCE; TAXONOMY; TECHNOLOGY;

ADMINISTRATION, ORAL; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EMULSIFYING AGENTS; EMULSIONS; INTESTINAL ABSORPTION; LASERS; LIGHT; MEMBRANES, ARTIFICIAL; MICELLES; NEPHELOMETRY AND TURBIDIMETRY; PARTICLE SIZE; POLYETHYLENE GLYCOLS; SCATTERING, RADIATION; SOLUBILITY; SURFACE-ACTIVE AGENTS; TEMPERATURE;

EID: 60749084743     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802244318     Document Type: Article

References (36)

1. Borkovec, M. (1989). From micelles to microemulsion droplets: Size distribution, shape fluctuations and interfacial tensions. J. Phys. Chem., 91(10), 6268-6291.
2. Brogård, M., Troedsson, E., Thuresson, K., & Ljusberg-Wahren, H. (2007). A new standardized lipolysis approach for the characterization of emulsions and dispersions. J. Colloid. Interface Sci., 308, 500-507.
3. Ciu, S., Zhao, C. H., Chen, D., & He, Z. (2005). Self- microemulsifying drug delivery systems (SMEDDS) for improving in vitro dissolution and oral absorption of pueraria lobata isoflavoine. Drug Dev. Ind. Pharm., 31, 349-356.
4. Constantinides, P. P., Lancaster, C. M., Marcello, J., Chiossone, D. C., Orner, D., Hidalgo, I., Smith, P. L., Sarkahian, A. B., Yiv, S. H., & Owen, A. J. (1995). Enhanced intestinal absorption of a RGD peptide from water-in-oil microemulsions of different composition and particle size. J. Control. Release, 34, 109-116.
5. Constantinides, P., & Scalart, J. P. (1997). Formulation and physical characterisation of water-in-oil microemulsions containing long-versus medium-chain glycerides. Int. J. Pharm., 158, 57-68.
6. Cuiné, J. F., Charman, W. N., Pouton, C. W., Edwards, G. A., & Porter, C. H. (2007). Increasing the proportional content of surfactants (cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs. Pharm. Res., 24(4), 748-757.
7. Cuiné, J. F., Mcevoy, C. L., Charman, W. N., Pouton, C. W., Edwards, G. A., Benameur, H., & Porter, C. H. (2008). Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs. J. Pharm. Sci., 97(2), 993-1010.
8. Dahan, A., & Hoffman, A. (2005). Evaluation of chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs. Eur. J. Pharm. Sci., 24, 381-388.
9. Ditner, C. (2007). Untersuchung des Verdünnungsverhaltens selbstemulgierender Systeme. Master Thesis, University of Basel, Institute of Pharmaceutical Technology.
10. Fatouros, D. G., & Müllertz, A. (2008). In vitro lipid digestion models in design of drug delivery systems for enhancing oral bioavailability. Expert Opin. Drug Metab. Toxicol., 4(1), 65-76.
11. Galia, E., Nicolaides, E., Hörter, D., Löbenberg, R., Reppas, C., & Dressman, J. B. (1998). Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm. Res., 15(5), 698-705.
12. Gao, P., Rush, B., Pfund, W., Huang, T., Bauer, J., Morozowich, W., Ming-Shang, K., & Hageman, M. (2003). Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved Oral Bioavailability. J. Pharm. Sci., 92(12), 2386-2398.
13. Gursoy, R., & Benita, S. (2004). Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother., 58, 173-182.
14. Holm, R., & Jensen, I. H. M. (2006). Optimization of self-microemulsifying drug delivery systems (SMEDDS) using a D-optimal design and the desirability function. Drug Dev. Ind. Pharm., 32, 1025-1032.
15. Hong, J. Y., & Kim, J. K., Song, Y. K., Park, J. S., & Kim, C. K. (2006). A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption. J. Control. Release, 110, 332-338.
16. Iwanaga, K., Kushibiki, T., Miyazaki, M., & Kakemi, M. (2006). Disposition of lipid-based formulation in the intestinal tract affects the absorption of poorly water-soluble Drugs Biol. Pharm. Bull., 29(3), 508-512.
17. Kapitza, S. B., Michel, B., van Hoogevest, P., Leigh, M., & Imanidis, G. (2007). Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the caco-2 cell model. Eur. J. Pharm. Biopharm., 66, 146-158.
18. Khoo, S. M., Humberstone, A. J., Porter, C. H., Edwards, G., & Charman, W. (1998). Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int. J. Pharm., 155-164.
19. Kossena, G. A., Charman, W., Boyd, B. J., & Porter, C. H. (2005). Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drug. J. Pharm. Sci., 94(3), 481-492.
20. Kuentz, M., Wyttenbach, N., & Kuhlmann, O. (2007). Application of a statistical method to the absorption of a new model drug from micellar and lipid formulations- evaluation of qualitative excipient effects. Pharm. Dev. Technol., 12, 275-283.
21. Nielsen, F., Gibault, E., Ljusberg-Wahren, H., Arleth, L., Pedersen, J. S., & Müllertz, A. (2007). Characterization of prototype self-nanoemulsifying formulations of lipophilic compounds. J. Pharm. Sci., 96(4), 876-892.
22. O'Driscoll, C. (2002). Lipid-based formulations for the intestinal lymphatic delivery. Eur. J. Pharm. Sci., 15, 405-415.
23. Porter, C., & Charman, W. (2001). In vitro assessment of oral lipid based formulations. Adv. Drug Deliv. Rev., 50, S127-S147.
24. Porter, C. H., Kaukonen, A. M., Taillardat-Bertschinger, A., Boyd, B. J., O'Connor, J. M., Edwards, G. A., & Charman, W. (2004). Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: Study with halofantrine. J. Pharm. Sci., 93(5), 1110-1121.
25. Porter, C. H., Pouton, C., Cuine, J., & Chaman, W. (2008). Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv. Drug Deliv. Rev., 60, 673-691.
26. Porter, C. H., Trevaskis, N., & Charman, W. (2007). Lipid and lipid-based formulations: Optimizing the oral delivery of lipophilic drugs. Nat. Rev. Drug Discov., 6(3), 231-248.
27. Pouton, C. (1997). Formulation of self-emulsifying drug delivery systems. Adv. Drug Deliv. Rev., 25, 47-58.
28. Pouton, C. W. (2000). Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying, and self-microemulsifying drug delivery systems. Eur. J. Pharm. Sci., 11(2), S93-S98.
29. Pouton, C. W. (2006). Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system. Europ. J. Pharm. Sci., 29, 278-287.
30. Seeballuk, F., Lawless, E., Ashford, M., & O'Discoll, C. (2003). The effect of pluronic® block copolymers and cremophor® EL on intestinal lipoprotein processing and the potential link with P-glycoprotein in caco-2 cells. Pharm. Res., 20(7), 1085-1092.
31. Seeballuk, F., Lawless, E., Ashford, M., & O'Discoll, C. (2004). Stimulation of triglyceride-rich lipoprotein secretion by polysorbate 80: In vitro and in vivo correlation using caco-2 cells and a cannulated rat intestinal lymphatic model. Pharm. Res., 21(12), 2320-2326.
32. Sek, L., Porter, C., Kaukonen, A. M., &, Charman, W. (2002). Evaluation of the in-vitro digestion profiles for long and medium chain triglycerides and the phase behaviour of the lipolytic products. J. Pharm. Pharmacol., 54, 29-41.
33. Shen, H. R., & Zhong, M. K. (2006). Preparation and evaluation of self-emulsifying drug delivery systems (SMEDDS) containing atorvastatin. J. Pharm. Pharmacol., 58, 1183-1191.
34. Stokes, R. J., & Evans, D. F. (1997). Can we quantitatively model micelle formation and stability in fundamentals of interfacial engineering (pp. 219-222). Chichester: Wiley New York.
35. Takagi, T., Ramachandran, C. H., Bermejo, M., Yamashita, S., Yu, L., & Amidon, G. (2006). A provisional biopharmaceutical classification of top 200 oral drug products in the United States, Great Britain, Spain and Japan. Mol. Pharm., 3(6), 631-643.
36. Vertzoni, M., Fotaki, N., Kostewicz, E., Stippler, E., Leuner, C. H., Nicolaides, E., Dressman, J., & Reppas, C. H. (2004). Dissolution media simulating the intralumenal composition of the small intestine: Physiological issues and practical aspects. J. Pharm. Pharmacol., 56, 453-462.